You already know the vital importance of regular screening for all of your patients. And you know the need for frequent monitoring of your patients who are already on a regular therapy regimen. Cholestech can help streamline these processes for your practice by eliminating the inconvenience of dealing with an outside laboratory and following up with patients. Point-of-care testing yields immediate results, enabling testing and follow-up in a single patient visit. And Cholestech's cost effective solutions create a very positive reimbursement picture that can have a significant impact on your bottom line. All Cholestech products are backed by our exceptional 24/7 customer support. Here's how our systems can benefit your practice: LDX System | GDX System

Accuracy Comparable To Laboratory Tests

• Meets all relevant National Cholesterol Education Program (NCEP) guidelines for precision and accuracy
• Certified accurate by the CDC's Cholesterol Reference Method Laboratory Network (CRMLN) for total and HDL cholesterol

Complete Lipid Profile, Glucose, ALT, AST, and hs-CRP* In Just Minutes

• Fast, 3-step procedure saves time, enhances productivity
• Eliminates the anxiety of venipuncture; requires only a single drop of blood from a single fingerstick
• Provides immediate feedback for on-the-spot adjustment of therapy and improved patient compliance

*hs-CRP tests are for use in labs certified for nonwaived testing

Supports Effective Disease State Management

• Allows rapid and dependable identification of lipid disorders
• Enhances compliance through "teachable moments" between healthcare providers and patients
• During Project ImPACT Hyperlipidemia study:
  • 94% of patients tested with the Cholestech LDX System persisted with therapy over 25 months, compared to 40% persistence rates reported in medical literature.¹
  • 63% of patients met NCEP treatment goals compared with 8% to 33% in prior studies.¹
• Includes a CHD risk assessment feature
• Provides a liver enzyme (ALT and AST) test to monitor the potential side effects of cholesterol-lowering or diabetes drug therapies

¹ Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT:Hyperlipidemia. J AM Pharm Assoc (Wash) 2000; 40:157-65.

Provides Opportunity for Additional Practice Income

• Only CLIA-waived system of its kind
• Reimbursable
• Provides potential for additional billing revenue without additional staff
• Low system cost, fast system payback

Small, Tough, Portable

• Small, 21 x 12cm (8¼" x 4¾") footprint for easy tabletop usage and storage
• System includes an easy-to-use printer that provides multiple copies of test results
• Lightweight design ideal for office or other point-of-care applications
• Factory calibrated, with easy and inexpensive software upgrades

Accuracy Comparable to Laboratory Tests

• Certified by the National Glycohemoglobin Standardization Program (NGSP) for accuracy and precision

A1C in Just Minutes

• Fast, simple procedure saves time, enhances productivity
• Eliminates the anxiety of venipuncture; requires only a single drop of blood from a single fingerstick
• Provides immediate feedback for on-the-spot adjustment of therapy and improved patient compliance

Supports Effective Diabetes Management

• Allows rapid and dependable monitoring of your diabetic patients' A1C levels
• Immediate feedback of A1C results at the time of patient visits has been shown to result in significant improvement of glycemic control*
• Facilitates ADA guidelines for A1C testing at baseline and up to 4 times a year for patients with diabetes mellitus

*Cagliero E. Levina EV. Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999; 22(11): 1785-9.

Provides Opportunity for Additional Practice Income

• Reimbursable
• Provides potential for additional billing revenue without additional staff
• Low system cost, low cost-per-test, fast system payback